Shortly after, Reinhardt and colleagues used zing finger nucleases (artificial restriction enzymes) to specifically correct the LRRK2-G2019S mutation in isogenic iPSC lines, and demonstrated a direct link between the mutation and axonal length and sensitivity to PD stressors [36]. The gene discussed is LRRK2; the disease is Parkinson disease.